These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 22361769)

  • 1. Carbapenem resistance among Escherichia coli and Klebsiella pneumoniae in a tertiary care hospital in south India.
    Nagaraj S; Chandran SP; Shamanna P; Macaden R
    Indian J Med Microbiol; 2012; 30(1):93-5. PubMed ID: 22361769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occurrence, prevalence and genetic environment of CTX-M beta-lactamases in Enterobacteriaceae from Indian hospitals.
    Ensor VM; Shahid M; Evans JT; Hawkey PM
    J Antimicrob Chemother; 2006 Dec; 58(6):1260-3. PubMed ID: 17071956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae isolates from Turkey with OXA-48-like carbapenemases and outer membrane protein loss.
    Gülmez D; Woodford N; Palepou MF; Mushtaq S; Metan G; Yakupogullari Y; Kocagoz S; Uzun O; Hascelik G; Livermore DM
    Int J Antimicrob Agents; 2008 Jun; 31(6):523-6. PubMed ID: 18339523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features of patients with carbapenem nonsusceptible Klebsiella pneumoniae and Escherichia coli in intensive care units: a nationwide multicenter study in Taiwan.
    Chang YY; Chuang YC; Siu LK; Wu TL; Lin JC; Lu PL; Wang JT; Wang LS; Lin YT; Huang LJ; Fung CP
    J Microbiol Immunol Infect; 2015 Apr; 48(2):219-25. PubMed ID: 25074627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The determination of carbapenem resistance in Escherichia coli and Pneumoniae isolates related to nosocomial infections and the evaluation of risk factors.
    Budak S; Oncul O; Aktas Z; Acar A; Ozyurt M; Turhan V; Erdem H; Gorenek L
    Southeast Asian J Trop Med Public Health; 2014 Jan; 45(1):113-22. PubMed ID: 24964660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence of plasmid-mediated quinolone resistance in Klebsiella pneumoniae and Escherichia coli isolates possessing blaVIM-1 in Greece.
    Galani I; Souli M; Mitchell N; Chryssouli Z; Giamarellou H
    Int J Antimicrob Agents; 2010 Sep; 36(3):252-4. PubMed ID: 20580536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of the β-lactamases in Escherichia coli and Klebsiella pneumoniae from a tertiary care hospital in Riyadh, Saudi Arabia.
    Marie MA; John J; Krishnappa LG; Gopalkrishnan S
    Microbiol Immunol; 2013 Dec; 57(12):805-10. PubMed ID: 24117831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of TaqMan real-time polymerase chain reaction for the detection of the newly emerging form of carbapenem resistance gene in clinical isolates of Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii.
    Manchanda V; Rai S; Gupta S; Rautela RS; Chopra R; Rawat DS; Verma N; Singh NP; Kaur IR; Bhalla P
    Indian J Med Microbiol; 2011; 29(3):249-53. PubMed ID: 21860104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular surveillance and clinical outcomes of carbapenem-resistant Escherichia coli and Klebsiella pneumoniae infections.
    Huang SR; Liu MF; Lin CF; Shi ZY
    J Microbiol Immunol Infect; 2014 Jun; 47(3):187-96. PubMed ID: 23200553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of carbapenem-resistant Enterobacteriaceae in Austria, 2001-2010.
    Zarfel G; Hoenigl M; Würstl B; Leitner E; Salzer HJ; Valentin T; Posch J; Krause R; Grisold AJ
    Clin Microbiol Infect; 2011 Nov; 17(11):E5-8. PubMed ID: 21939472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ongoing epidemic of blaVIM-1-positive Klebsiella pneumoniae in Athens, Greece: a prospective survey.
    Psichogiou M; Tassios PT; Avlamis A; Stefanou I; Kosmidis C; Platsouka E; Paniara O; Xanthaki A; Toutouza M; Daikos GL; Tzouvelekis LS
    J Antimicrob Chemother; 2008 Jan; 61(1):59-63. PubMed ID: 17999975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of carbapenem-resistant Escherichia coli and Klebsiella pneumoniae producing NDM-1 in Lebanon.
    El-Herte RI; Araj GF; Matar GM; Baroud M; Kanafani ZA; Kanj SS
    J Infect Dev Ctries; 2012 May; 6(5):457-61. PubMed ID: 22610714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance.
    Shahid M; Malik A; Akram M; Agrawal LM; Khan AU; Agrawal M
    Int J Infect Dis; 2008 May; 12(3):256-64. PubMed ID: 17981482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance to extended-spectrum beta-lactams by the emergence of SHV-12 and the loss of OmpK35 in Klebsiella pneumoniae and Escherichia coli in Malaysia.
    Palasubramaniam S; Muniandy S; Navaratnam P
    J Microbiol Immunol Infect; 2009 Apr; 42(2):129-33. PubMed ID: 19597644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of integrons in clinical isolates of betalactamase-producing Escherichia coli and Klebsiella pneumoniae in Iran.
    Zeighami H; Haghi F; Hajiahmadi F
    J Chemother; 2015 Jun; 27(3):145-51. PubMed ID: 24571248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outbreak of carbapenem-resistant Klebsiella pneumoniae producing KPC-3 in a tertiary medical centre in Israel.
    Samra Z; Ofir O; Lishtzinsky Y; Madar-Shapiro L; Bishara J
    Int J Antimicrob Agents; 2007 Dec; 30(6):525-9. PubMed ID: 17931835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First detection of a carbapenem-hydrolyzing metalloenzyme in two enterobacteriaceae isolates in Spain.
    Tórtola MT; Lavilla S; Miró E; González JJ; Larrosa N; Sabaté M; Navarro F; Prats G
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3492-4. PubMed ID: 16048967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence of extended-spectrum beta-lactamases and plasmid-mediated AmpC beta-lactamases in Enterobacteriaceae isolated from long-term care facilities in Korea.
    Yoo JS; Byeon J; Yang J; Yoo JI; Chung GT; Lee YS
    Diagn Microbiol Infect Dis; 2010 Jul; 67(3):261-5. PubMed ID: 20462727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of specific inhibitors on metallo-β-carbapenemases detected in Escherichia coli and Klebsiella pneumoniae isolates.
    Abbas HA; Kadry AA; Shaker GH; Goda RM
    Microb Pathog; 2019 Jul; 132():266-274. PubMed ID: 31096002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent healthcare-associated community-onset infections due to Klebsiella pneumoniae producing VIM-1 metallo-beta-lactamase.
    Poulou A; Spanakis N; Pournaras S; Pitiriga V; Ranellou K; Markou F; Tsakris A
    J Antimicrob Chemother; 2010 Dec; 65(12):2538-42. PubMed ID: 20876622
    [